Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cornberg

Showing results (201-210 of 350) with videos related to

Pageof 35
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 28, 2021
Distinct Immune Imprints of Post-Liver Transplantation Hepatitis C Persist Despite Viral ClearanceAmare Aregay, Bastian Engel, Kerstin Port, et al.
Liver Cancer|March 1, 2019
HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus InfectionSolomon Owusu Sekyere, Bernhard Schlevogt, Friederike Mettke, et al.
Plos One|February 6, 2013
Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world settingBenjamin Maasoumy, Kerstin Port, Antoaneta Angelova Markova, et al.
Hepatology (Baltimore, Md.)|January 7, 2021
Eradication of Chronic HCV Infection: Improvement of Dysbiosis Only in Patients Without Liver CirrhosisFreya Wellhöner, Nico Döscher, Franziska Woelfl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 27, 2019
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAsFrank Tacke, Klaus H W Boeker, Hartwig Klinker, et al.
Alimentary Pharmacology & Therapeutics|January 12, 2024
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infectionLisa Sandmann, Elisabetta Degasperi, Kerstin Port, et al.
Frontiers in Immunology|May 8, 2026
Particularly strong immune response to influenza vaccination in patients with decompensated liver cirrhosis linked to systemic inflammationJanyn Heisig, Valerie Ohlendorf, Nhan Nguyen, et al.
JHEP Reports : Innovation in Hepatology|March 4, 2024
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatmentAndré Gömer, Katja Dinkelborg, Mara Klöhn, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Long-term follow-up after successful interferon therapy of acute hepatitis CJohannes Wiegand, Elmar Jäckel, Markus Cornberg, et al.
Plos One|June 26, 2020
Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascitesLena Stockhoff, Marie Schultalbers, Tammo L Tergast, et al.
Pageof 35

Showing results (201-210 of 350) with videos related to

Sort By:
Pageof 35
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 28, 2021
Distinct Immune Imprints of Post-Liver Transplantation Hepatitis C Persist Despite Viral ClearanceAmare Aregay, Bastian Engel, Kerstin Port, et al.
Liver Cancer|March 1, 2019
HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus InfectionSolomon Owusu Sekyere, Bernhard Schlevogt, Friederike Mettke, et al.
Plos One|February 6, 2013
Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world settingBenjamin Maasoumy, Kerstin Port, Antoaneta Angelova Markova, et al.
Hepatology (Baltimore, Md.)|January 7, 2021
Eradication of Chronic HCV Infection: Improvement of Dysbiosis Only in Patients Without Liver CirrhosisFreya Wellhöner, Nico Döscher, Franziska Woelfl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 27, 2019
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAsFrank Tacke, Klaus H W Boeker, Hartwig Klinker, et al.
Alimentary Pharmacology & Therapeutics|January 12, 2024
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infectionLisa Sandmann, Elisabetta Degasperi, Kerstin Port, et al.
Frontiers in Immunology|May 8, 2026
Particularly strong immune response to influenza vaccination in patients with decompensated liver cirrhosis linked to systemic inflammationJanyn Heisig, Valerie Ohlendorf, Nhan Nguyen, et al.
JHEP Reports : Innovation in Hepatology|March 4, 2024
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatmentAndré Gömer, Katja Dinkelborg, Mara Klöhn, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Long-term follow-up after successful interferon therapy of acute hepatitis CJohannes Wiegand, Elmar Jäckel, Markus Cornberg, et al.
Plos One|June 26, 2020
Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascitesLena Stockhoff, Marie Schultalbers, Tammo L Tergast, et al.
Pageof 35